Radioisotope shortage imminent after reactor restart delay: 5 things to know

A production delay at three European nuclear reactors will result in a shortage of radioisotopes crucial for the detection of disease in medical imaging.

Advertisement

The shortage is expected to affect radioisotopes Mo-99 and Tc-99m, according to an Oct. 14 letter from Nuclear Medicine Europe shared by the Society of Nuclear Medicine and Molecular Imaging. 

Here are five things to know about the shortage:

  1. The shortage began the week of Oct. 14 and is expected to continue until November.
  2. Shortages may amount to 40% of the usual radioisotope requirements.
  3. Shortages will vary by geographic region.
  4. Stakeholders are advised to communicate with their suppliers.
  5. The NMEU was not able to provide a planned day for production to restart.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Radiology

Advertisement

Comments are closed.